---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-023323"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2026-01-27T23:59:59+00:00"
generated_at: "2026-05-16T07:45:29.034787+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized

## Summary
- Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).
- Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.
- Board authorized new $10B share repurchase program; $750M remained under prior authorization as of Dec 31.
- Quarterly dividend raised to $0.78/share, payable March 31, 2026 to holders of record March 17.
- 2026 guidance: revenue $76.5B-$80B, EPS $29.10-$31.50, adjusted EBITDA $15.55B-$16.45B.

## SEC filing metadata
- accession: 0001193125-26-023323
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2026-01-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312526023323/0001193125-26-023323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312526023323/hca-20260127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-023323
- JSON: https://secwatch.observer/filing/0001193125-26-023323.json
- Plain text: https://secwatch.observer/filing/0001193125-26-023323.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.